Advanced search

Find pages with...
Then narrow your results by...

About 1,833 search results

Chapter 3 - Specific Registration Information by Feed Type - Animals - Canadian Food Inspection Agency

Aug 13, 2019 ... statement: "Feeding this product to cattle, sheep, deer or other ruminants is illegal and is subject to fines or other punishment under the Health of Animals Act." 3.8 Flavouring Agents Registration requirements of flavouring agents Flavouring ingredients Single flavouring ingredients must be approved by the CFIA prior to their importation, manufacture, or sale

Consulting with Canadians

Jul 31, 2019 ... Regulations (MMER for Back River Project. Agile regulations for advanced therapeutic products and clinical trials Open - accepting input Food and drug | Health | Policy July 18, 2019 to Aug 30, 2019 2019-07-18 2019-08-30 Health Canada The goal of this consultation is to seek feedback on what Health Canada should consider in developing new clinical trials regulations

Promotion of health and charitable registration

Jul 15, 2019 ...Promotion of health and charitable registration This guidance explains how the Canada Revenue Agency (CRA) interprets and applies the law as it relates to the promotion of health and charitable registration. It was developed in consultation with stakeholders in the charitable sector. While the CRA is always interested in feedback on its guidance products

Register for the cannabis stamping regime

Jun 13, 2019 ... or prescription cannabis drugs You can register for the cannabis stamping regime at the same time as you apply for a cannabis licence under the Excise Act, 2001. How to register for the cannabis stamping regime You can register for the cannabis stamping regime by using Form L301, Registration for Cannabis Stamping Regime. After you register for the cannabis stamping

Food and Drug Regulations,_c._870/nifnev.html

Jun 3, 2019 ... a risk to public health or safety, including the risk of a controlled drug being diverted to an illicit market or use; and (i) if the licensed dealer produces a controlled drug, the quantity that they may produce and the authorized production period. Validity G.02.008 A dealer’s licence is valid until the expiry date set out in the licence or, if it is earlier

Natural Health Products Management of Applications Policy

May 27, 2019 ... in navigating the application process and should be used in conjunction with associated guidance documents linked throughout this document. This policy does not apply to site licence or clinical trial applications for NHPs. It also does not apply to applications for other health products including, drugs, medical devices, biologic and genetic therapies, veterinary drugs

Precursor Control Regulations

Jun 3, 2019 ... Control Regulations SOR/2002-359 CONTROLLED DRUGS AND SUBSTANCES ACT Registration 2002-09-24 Precursor Control Regulations P.C. 2002-1615 2002-09-24 Whereas a provision of the annexed Regulations deals with the communication of information obtained under the Regulations to certain classes of persons, and in the opinion of the Governor in Council, pursuant

Requirements and process: Cannabis Licensing Application Guide

Jun 13, 2019 ... at each site. The address of each additional authorized site will appear on the licence, if it is issued. Intent to sell Indicate if there is intent to sell the product of the research (e.g., cannabis plants and/or cannabis plant seeds to a licensed cultivator, researcher, cannabis drug licence or exemption holder). Type of research Indicate the type(s

Cannabis Regulations

Jun 3, 2019 ... ACT CONTROLLED DRUGS AND SUBSTANCES ACT FOOD AND DRUGS ACT Registration 2018-06-27 Cannabis Regulations P.C. 2018-948 2018-06-26 Her Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to subsection 30(1)Footnote a of the Food and Drugs ActFootnote b, subsection 55(1)Footnote c of the Controlled Drugs

Guidance Document : Post-Notice of Compliance (NOC) Changes: Quality Document

Aug 1, 2019 ... as these factors may relate to the safety or effectiveness of the drug product. The changes included in this reporting category may be implemented by the sponsor without the prior review by Health Canada of the data supporting such a change. All Level III changes should be submitted using the Post-Notice of Compliance Changes: Notices of Change (Level III) Form. Supporting

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: